Abstract:Aims
To determine the occurrence of microalbuminuria in young people with Type 1 diabetes mellitus followed prospectively for 2 years and to relate the presence of persistent elevations in urinary albumin excretion (UAE) to age, diabetes duration, puberty and other factors.
Methods
During a 2 year period, random urine samples were obtained from 471 patients, aged 8–18 years (mean ± SD 12.9 ± 2.3 years) with Type 1 diabetes duration 5.6 ± 3.0 years, as part of routine clinical care. Urine albumin and creatini… Show more
“…Other studies have reported similar results: the prevalence rate of microalbuminuria was estimated to be 5.9% in children with a mean age of 12.7 years and a diabetes duration of 5.1 years (4). Another study in children (mean age 12.9 years) has revealed that persistent microalbuminuria was present in 9.3% (13). The present survey also showed that intermittent microalbuminuria was not a predictive factor for the progression of microalbuminuria and that in a real-world setting, intermittent microalbuminuria has little prognostic significance in adolescents with type 1 diabetes (1,4,12,14).…”
Section: Discussionsupporting
confidence: 62%
“…Several cross-sectional studies demonstrated that 6-25% of patients between 15 and 20 years of age develop microalbuminuria (1,4,8,9,10). Because the natural history of microalbuminuria in adolescents with type 1 diabetes is often not as consistent and clear as in adults, there is ongoing discussion about predictors of persistent microalbuminuria and nephropathy (4,8,11,12,13). Some studies have shown that half of the probands with type 1 diabetes and microalbuminuria have normoalbuminuria at the end of puberty (4,11).…”
Objective: To identify risk factors for the development and progression of untreated persistent microalbuminuria in children and adolescents with type 1 diabetes. Design and methods: A total number of 683 children and adolescents with type 1 diabetes recruited from the prospective nationwide German and Austrian diabetes survey (DPV) were included in the analysis. Inclusion criteria were onset of type 1 diabetes under the age of 11 years, diabetes duration of more than 1 year and continuous follow-up over 5 years with at least two documented urine analyses per year. Subjects treated with angiotensin-converting enzyme inhibitors were excluded. Risk factors such as sex, body mass index SDS, diabetes duration, HbA1c, total cholesterol, HDL-cholesterol, LDL-cholesterol, systolic and diastolic blood pressure, and immigrant status were analysed by logistic regression. Results: At baseline (age 10.5G0.1 years, diabetes duration 4.6G2.4 years and HbA1c 7.4G1.1%), 75.6% of children had normoalbuminuria, 15.7% had intermittent microalbuminuria, 8.6% had persistent microalbuminuria and 0.1% had macroalbuminuria. After a follow-up of 5 years, 59.4% of adolescents continued to have normoalbuminuria, 18.4% had progression, 15.2% had regression of microalbuminuria, and in 6.9% of the subjects, microalbuminuria remained unchanged. We found significant associations between persistent microalbuminuria at baseline and during each year of follow-up (P!0.0001). Logistic regression analysis identified diabetes duration and immigrant status as significant factors for microalbuminuria (PZ0.009 and PZ0.009). Conclusions: The survey in a real-world setting shows that diabetes duration and immigrant status are risk factors for the development and progression of untreated microalbuminuria in children and adolescents with type 1 diabetes.
“…Other studies have reported similar results: the prevalence rate of microalbuminuria was estimated to be 5.9% in children with a mean age of 12.7 years and a diabetes duration of 5.1 years (4). Another study in children (mean age 12.9 years) has revealed that persistent microalbuminuria was present in 9.3% (13). The present survey also showed that intermittent microalbuminuria was not a predictive factor for the progression of microalbuminuria and that in a real-world setting, intermittent microalbuminuria has little prognostic significance in adolescents with type 1 diabetes (1,4,12,14).…”
Section: Discussionsupporting
confidence: 62%
“…Several cross-sectional studies demonstrated that 6-25% of patients between 15 and 20 years of age develop microalbuminuria (1,4,8,9,10). Because the natural history of microalbuminuria in adolescents with type 1 diabetes is often not as consistent and clear as in adults, there is ongoing discussion about predictors of persistent microalbuminuria and nephropathy (4,8,11,12,13). Some studies have shown that half of the probands with type 1 diabetes and microalbuminuria have normoalbuminuria at the end of puberty (4,11).…”
Objective: To identify risk factors for the development and progression of untreated persistent microalbuminuria in children and adolescents with type 1 diabetes. Design and methods: A total number of 683 children and adolescents with type 1 diabetes recruited from the prospective nationwide German and Austrian diabetes survey (DPV) were included in the analysis. Inclusion criteria were onset of type 1 diabetes under the age of 11 years, diabetes duration of more than 1 year and continuous follow-up over 5 years with at least two documented urine analyses per year. Subjects treated with angiotensin-converting enzyme inhibitors were excluded. Risk factors such as sex, body mass index SDS, diabetes duration, HbA1c, total cholesterol, HDL-cholesterol, LDL-cholesterol, systolic and diastolic blood pressure, and immigrant status were analysed by logistic regression. Results: At baseline (age 10.5G0.1 years, diabetes duration 4.6G2.4 years and HbA1c 7.4G1.1%), 75.6% of children had normoalbuminuria, 15.7% had intermittent microalbuminuria, 8.6% had persistent microalbuminuria and 0.1% had macroalbuminuria. After a follow-up of 5 years, 59.4% of adolescents continued to have normoalbuminuria, 18.4% had progression, 15.2% had regression of microalbuminuria, and in 6.9% of the subjects, microalbuminuria remained unchanged. We found significant associations between persistent microalbuminuria at baseline and during each year of follow-up (P!0.0001). Logistic regression analysis identified diabetes duration and immigrant status as significant factors for microalbuminuria (PZ0.009 and PZ0.009). Conclusions: The survey in a real-world setting shows that diabetes duration and immigrant status are risk factors for the development and progression of untreated microalbuminuria in children and adolescents with type 1 diabetes.
“…In other studies even higher percentages of both have been found [43]. Significant association between the occurrence of microalbuminuria or proteinuria and poor glucose control has been confirmed [26,43]. In addition to poor glycemic control, clinical markers of insulin resistance were associated with its development [44].…”
Section: Microalbuminuria In Different Childhood Diseasesmentioning
confidence: 86%
“…Microalbuminuria was most extensively investigated in children with both type 1 and type 2 diabetes [25,26] and its significant role established. In recent years its assessment has been utilized as a screening test for the presence of diabetes-related kidney disease [38].…”
Section: Microalbuminuria In Different Childhood Diseasesmentioning
confidence: 99%
“…Unfortunately, there are no studies yet, investigating the role of microalbuminuria in children as cardiovascular risk factor later in adult life, which is important future task. Anyway, the clinical significance of microalbuminuria in diabetic children has been confirmed [25,26] as well as in some other diseases in children [27][28][29][30]. Some small intervention studies have also been conducted, suggesting that early intervention with medications is likely to be beneficial in children too [31,32].…”
Microalbuminuria in adults has been found to be an early indicator of both renal and systemic vascular disease, as well as significant cardiovascular risk predictor and therapeutic marker. Its role in essential hypertension in adults has also been well established. As diseases like hypertension and obesity have their roots in childhood and are already present in children, influencing the morbidity in adulthood, the role of microalbuminuria has been extensively investigated in children as well. Most investigations have been performed in diabetic children, confirming its clinical significance. There is also enough evidence to suggest that microalbuminuria in obese children should be taken as seriously as in children with diabetes. In children with hypertension rare studies also indicate that its presence identifies hypertensive children with higher risk, although the exact role has to be confirmed in prospective and larger studies. The mechanisms of microalbuminuria onset could be the result of renal damage secondary to hypertension or underlying renal and systemic endothelial dysfunction. Evidence from small intervention studies in children with microalbuminuria also suggests that early intervention with antihypertensive drugs is likely to be beneficial, pointing out the role of microalbuminuria as a therapeutic marker in children too. In addition, we have to stress the importance of follow-up of children with microalbuminuria, confirmation of its persistence and identification of progression. However, longitudinal prospective studies in children, investigating its future cardiovascular risk, are still lacking.
Key Points
Question
How do individuals narrate their experiences of living with type 1 diabetes during early emerging adulthood (the developmental life stage roughly spanning between the ages of 18 and 24 years)?
Findings
This qualitative study involved in-depth interviews with 33 emerging adults with type 1 diabetes. Narrative analysis identified 3 distinct story types encompassing differing perceptions of living with type 1 diabetes (3i), termed
ingrained
(characterized by actively integrating diabetes within one’s life),
intrusive
(characterized by struggles to accept diabetes and a sense of striving for control), and
inconspicuous
(characterized by attempts to minimize attention toward diabetes to protect one’s sense of normalcy).
Meaning
The 3i conceptual framework provides a means by which differing emerging adult perceptions of type 1 diabetes can be recognized and articulated, which may help health care professionals better individualize their approaches to self-management support during the transitioning years.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.